Poster
MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that does not show signs of peripheral toxicity in preclinical models
Author
Kees Bol
Condition
cancer
Drug target
CD137, PD-L1
Drug moa
CD137 agonist and immune checkpoint inhibitor
Date
2020
Source url
s3://convoke-optic-posters/a0b98d89-5d99-49bc-a53f-579b41ef4a5c.pdf
3 organizations
1 product
Product
MCLA-145Organization
Merus NVOrganization
PD-value BVOrganization
Incyte